TechCrunch February 21, 2019
Jonathan Shieber

About 20 years ago, a medical device startup called Intuitive Surgical debuted the da Vinci robot and changed surgical practices in operating rooms across the United States.

The da Vinci ushered in the first age of robotic-assisted surgical procedures with a promise of greater accuracy and quicker recovery times for patients undergoing certain laparoscopic surgeries.

For a time, it was largely alone in the market. It has skyrocketed in value since 2000, when the stock first debuted on public markets. From the $46 million that the company initially raised in its public offering to now, with a market capitalization of nearly $63 billion, Intuitive has been at the forefront of robotic-assisted surgeries, but now a new crop of startups...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Metaverse/VR, Provider, Robotics/RPA, Technology
Advocate opens new ASC, cardiovascular center in Chicago suburb
5 numbers shaping the ASC industry in 2025
The biggest threat to cardiology independence
Procedures that will drive ASC growth in 2025
ASCs to capitalize on growth in 2025

Share This Article